Seminars in Oncology
Volume 35, Supplement 2 , Pages S31-S38, April 2008

Emerging Agents in the Treatment of Anthracycline- and Taxane-Refractory Metastatic Breast Cancer

The University of Texas MD Anderson Cancer Center, Houston, TX.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Drs Dean-Colomb and Esteva have no relevant relationships with commercial interests to disclose.

PII: S0093-7754(08)00043-2

doi:10.1053/j.seminoncol.2008.02.008

Seminars in Oncology
Volume 35, Supplement 2 , Pages S31-S38, April 2008

Article Tools

* Image Usage & Resolution